News
1d
Medpage Today on MSNAlternative to Anti-VEGF Shows Safety, Efficacy in Diabetic Macular EdemaA single intravitreal injection of UBX1325 (foselutoclax) was shown to be safe in patients with diabetic macular edema. The ...
4d
News-Medical.Net on MSNDiabetes drugs GLP-1RA and SGLT2i lower dementia risk in older adults, study findsA large population-based study found that GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2is), two classes of ...
Experts say 85% price drop in empagliflozin expected to boost SGLT2 usage; SGLT-2 class of drugs account for 25-30% of all diabetes prescriptions ...
"We were expecting prices of anti-diabetic medicine Empagliflozin to crash as the medicine went off patent earlier this month. The industry was expecting a price drop by as much as 90%. The same ...
finds that people with type 2 diabetes who take two common anti-diabetes medications had a reduced risk of Alzheimer’s and associated dementias. Specifically, GLP-1RA was linked to a 33% lower ...
14don MSN
Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...
New Delhi: A common diabetes drug can help reduce pain in people with knee osteoarthritis (OA) and obesity, as well as delay ...
finds that people with type 2 diabetes who take two common anti-diabetes medications had a reduced risk of Alzheimer’s and associated dementias. As the average age of the population steadily ...
A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying ...
5d
MedPage Today on MSNMedicaid Often Restricts Access to Heart-Protective Diabetes AgentsMedicaid plans often put up barriers around newer classes of diabetes medications that offer cardioprotection, according to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results